Dr. Reddy’s gets 13 USFDA observations for Visakhapatnam facility

09 Mar 2017 Evaluate

Dr. Reddy’s Laboratories’ formulation manufacturing facility at Duvvada, Visakhapatnam, has been audited by the US Food and Drug Administration (USFDA), and the audit has been completed on March 8, 2017. The company has been issued a Form 483 with 13 observations, which it is addressing.

Earlier, the company’s API manufacturing plant at Miryalaguda, had been audited by the USFDA and the audit had been completed on February 21, 2017. The company had been issued a Form 483 with three observations, which it was addressing.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.



Dr. Reddys Lab Share Price

1218.40 9.95 (0.82%)
30-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1218.40
Cipla 1323.95
Zydus Lifesciences 885.20
Lupin 2151.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×